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Retroviral integration: Site matters
Mechanisms and consequences of retroviral integration site selection
Jonas Demeulemeester1)2)3), Jan De Rijck1), Rik Gijsbers2) and Zeger Debyser1)
Here,we reviewgenomic targetsiteselectionduring retroviral
integrationasamultistepprocess inwhichspecificbiasesare
introducedateach level.Thefirstasymmetriesare introduced
whenthevirus takesaspecific route into thenucleus.Next,by
co-optingdistincthostcofactors, the integrationmachinery is
guided toparticular chromatincontexts.As theviral integrase
captures a local target nucleosome, specific contacts
introduce fine-grained biases in the integration site distri-
bution. In vivo, the established population of proviruses is
subject to both positive and negative selection, thereby
continuously reshaping the integration site distribution. By
affecting stochastic proviral expression as well as the
mutagenic potential of the virus, integration site choice may
be an inherent part of the evolutionary strategies used by
different retroviruses to maximise reproductive success.
Keywords:.cofactor; HIV-1; integration; latency; MLV; retrovirus;
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Introduction
One of the defining events in the retroviral lifecycle is insertion
of the reverse transcribed viral RNA genome into a host-cell
chromosome. This step, catalysed by the viral integrase protein
(IN) establishes a stably integrated version of the virus, referred
to as the provirus. The provirus provides a lasting template for
viral gene expression, and its activity drives production of
progeny virions by the infected cell. As the provirus constitutes
an integralpartof thegenome, its fate is intimately linkedto that
of the infected cell: retroviruses persist in a host for the lifetime
of the infected cells or their progeny.
Retroviral integration is not a random process: different
retroviral genera (alpha- through epsilon-, lenti- and spuma-
retroviruses) favour distinct chromatin environments for
integration. Lentiviruses, such as the Human Immunodefi-
ciency Virus Type-1 (HIV-1) for instance show a preference to
integrate into actively transcribed regions [1]. Conversely,
gammaretroviruses such as the Murine Leukaemia Virus
(MLV) target active promoter-proximal as well as distal
enhancer elements [2–5]. The deltaretrovirus Human T
Lymphotropic Virus Type 1 (HTLV-1) integrates more fre-
quently in or near transcriptionally active areas [6, 7]. Tree-
based clustering results of retroviruses based on their
integration preferences generally map well onto the retroviral
phylogenetic tree [6]. This deeply rooted evolutionary link
suggests that integration site selection is part of the strategy
employed by retroviruses to maximise their replicative fitness.
The advent of next-generation sequencing methods to
identify integration sites [8], the resolution of crystal structures
of the integration machinery (the intasome complex) [9, 10] as
well as the identification of various host-encoded integration
cofactors [11–14] allow us to paint a detailed picture of the
retroviral integration site selection process. In this review essay,
we attempt toput together thepieces required to do just that.We
provide a detailed view of the known determinants of the
integration site distribution and argue that target site selection
can indeed be subject to evolutionary optimisation through
natural selection. Finally, we discuss how the integration site
distribution is further shapedbyselectionforces inthehost.Most
of the work in the field has focused on HIV and MLV owing to
their relevance as a human pathogen and gene therapy vector,
respectively. In the latter case, some of the implications of
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retroviral integration site selection have already become
painfully clear. Treatmentwith gammaretroviral vectors in gene
therapy clinical trials has led to clonal expansion and leukaemia
development due to viral Long Terminal Repeat (LTR)-driven
activation of proto-oncogenes (i.e. insertional mutagenesis) in a
subset of patients [15, 16]. Also in HIV-infected patients, similar
processes have recently become evident [17–19]. Exploiting the
extensive body of research on HIV and MLV, we will mainly
discuss integration site selection as it occurs for lenti- and
gammaretroviruses. Nevertheless, many of the mechanisms
discussed here generalise to all retroviruses.
Nuclear entry route, an early determinant
of viral integration site selection
The infectious cycle of retroviruses kicks off when specific
receptors on a host cell are engaged by the viral envelope
(Env) protein (Fig. 1A). These contacts culminate in the fusion
of viral and cellular membranes and the concomitant release
of the viral core into the cytoplasm. On its way towards the
nucleus, the viral RNA genome is reverse transcribed into a
double-stranded DNA copy. The preintegration complex (PIC),
consisting of the viral DNA associated with a specific set of
viral and host proteins, then reaches the nuclear envelope. To
Figure 1. Early stages of retroviral replication and nuclear entry. A:
During attachment, the viral envelope engages specific host receptors
leading to membrane fusion and entry of the viral core into the
cytoplasm. The viral RNA genome is reverse transcribed into a dsDNA
copy as the complex is trafficked towards the nucleus. Gammare-
troviral preintegration complexes (PICs) wait for mitosis and nuclear
envelope disassembly to access the chromatin. Lentiviral PICs traverse
a nuclear pore complex (NPC). B: In gammaretroviruses, p12 stabilises
the capsid and tethers the PIC to a condensed chromosome during
mitosis. The complex segregates to one of the daughter cells. Upon
exit from mitosis, the nuclear envelope reassembles, p12 is released
and the capsid uncoats. The MLV intasome complex is set free and
integration is likely to occur quickly afterwards, in the vicinity. C: In
lentiviruses, nuclear import and integration are tightly coupled. The viral
capsid core docks onto the NPC. Completion of reverse transcription
may promote uncoating of the docked capsid. The released PIC core
engages nucleoporins and import factors to gain access to the
nucleoplasm. Integration occurs on a first-come, first served basis.
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overcome this physical barrier and gain access to the host-cell
chromatin, retroviruses have evolved different strategies.
Taking distinct paths into the nucleus implies that the first
chromatin environments generally encountered by various
retroviral PICs are also different. If integration takes place
quickly after nuclear entry, as results seem to suggest, the
result is a first bias in the integration site distribution [20–23].
Tethering of the gammaretroviral capsid to
mitotic chromatin
Gammaretroviruses, such as MLV only infect dividing cells.
They encode an accessory p12 protein in the group-specific
antigen (gag) gene [24]. On the one hand, p12 interacts with and
stabilises the capsid shell of the PIC through its N-terminal
portion, preventing untimely uncoating and ensuring comple-
tion of reverse transcription [24, 25]. When the infected cell
enters mitosis and the nuclear envelope breaks down, the C-
terminal region binds to a condensed chromosome, effectively
tethering the capsid-associated PIC to the chromatin (Fig. 1A
and B) [26]. The complex segregates along with the chromo-
somes to one of the daughter cells. Upon exit from mitosis, the
nuclear envelope reassembles andp12 is released, orchestrating
capsid uncoating [27]. The MLV intasome, associated with
various host and viral factors, is set free in the nucleoplasm
(Fig. 1B). If integration happens shortly after the intasome first
encounters chromatin, near the point of release, then site
selection may be influenced by the chromatin-binding prefer-
ences of p12. Abolishing the MLV p12-chromatin interaction by
mutagenesis blocks viral replication, and can be rescued by
introducing other chromatin tethers into the mutant p12. While
thepreferenceof the rescuedviruses for enhancersdidnotdiffer
fromwild type, some subtle variations in the distributionswere
observed [27].Conceivably,similarbroadchromatinrecognition
profiles of p12 and the other tethersmay hide p12’s effect on site
selection.
In conclusion, p12 is clearly required for integration per se.
However, it does not appear to induce major biases in
integration site selection, potentially owing to its broad
chromatin recognition. As we will see, host cofactors are
acting together with IN downstream of p12 to further pin down
the gammaretroviral integration site [12–14].
Lentiviral capsid docking, uncoating and nuclear
import
Lentiviruses have evolved the ability to traverse nuclear pore
complexes (NPC), allowing them to infect non-dividing,
terminally differentiated cells. The viral capsid core is believed
to dock onto the cytoplasmic side of the NPC through
interactions with Nup358/RanBP2 (Fig. 1A and C) [28, 29].
Termination of reverse transcription has been reported to
promote uncoating of the docked capsid and release of the PIC
[30]. Through subsequent engagement of other nucleoporins
such as Nup153 and Nup98-Nup96, and import factors such as
Transportin-SR2 (TRN-SR2, TNPO3), the released PIC gains
access to the nucleoplasm [28, 31, 32].
The first nuclear subcompartment a lentiviral PIC
encounters is the NPC-associated chromatin. NPCs establish
cone-like heterochromatin-exclusion zones at their nuclear
baskets (reviewed in [33, 34], Fig. 1C). In contrast, amassment
of heterochromatin into repressive lamin-associated domains
occurs adjacent to NPCs (Fig. 1C) [35].
Studies using a variety of fluorescence microscopy
approaches have reported that the HIV PIC and integrated
provirus preferentially localise to areas of euchromatin at the
nuclear periphery [21–23]. Furthermore, genes recurrently
targeted for HIV integration are closely associated with NPCs
[20]. These results suggest that lentiviral integration site
selection simply occurs in those regions of the chromatin that
it encounters first as it enters the nucleus (Fig. 1C). This initial
selection based on nuclear architecture may contribute to the
lentiviral integration bias towards regions enriched in open
chromatin marks.
The findings evince a tight coupling between lentiviral
nuclear import and integration site choice. Indeed, depletion
of the nuclear import factor TRN-SR2 or NPC constituents
Nup358/RanBP2, Nup153, Nup98-Nup96 or Tpr altered the
HIV integration site distribution, suggesting these proteins
play a role in the nuclear import/integration pathway or in the
maintenance of chromatin topology [29, 31, 36–38].
As the viral capsid affects the mode of nuclear import, it
too has been shown to modulate site selection [28, 29, 36].
When the entire HIV gag is replaced by its MLV counterpart,
the hybrid virus integrates less into the gene-dense environ-
ments underlying NPCs, likely reflecting an altered mode of
nuclear entry [29]. Moreover, several HIV capsid mutants that
perturb binding to Nup358, Nup153 or cyclophilin A and/or
alter capsid stability also affect integration site selection [28,
39, 40]. The results further underscore the close connection
between nuclear import and integration.
Host cofactors steer the PIC to specific
chromatin environments
Upon entry or release of the PIC into the nucleus, IN hijacks
host proteins to guide the complex to specific chromatin
contexts. This likely represents an evolutionary ancient
strategy as it is also adopted by LTR retrotranposons. In the
case of lentiviruses, the co-opted protein is Lens Epithelium-
Derived Growth Factor/p75 (LEDGF/p75) [11, 41]. Gamma-
retroviral PICs on the other hand adopt Bromodomain and
Extraterminal domain (BET) proteins [12–14].
LEDGF/p75 tethers lentiviral PICs to actively
transcribed chromatin
LEDGF is a ubiquitously expressed chromatin reader encoded
by the PSIP1 gene. It is a member of the Hepatoma-Derived
Growth Factor (HDGF) family, characterised by a conserved N-
terminal PWWP domain (named after its signature Pro-Trp-
Trp-Pro motif, Fig. 2A). The LEDGF PWWP specifically binds
H3K36me3-modified nucleosomes, a hallmark of active tran-
scription [42, 43] (reviewed in [44]). In contrast to the p52
splice variant, the p75 isoform harbours a C-terminal
integrase-binding domain (IBD), which links it to a variety
of cellular proteins. Aside from LEDGF/p75, only its close
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paralog HDGF-Related Protein 2 (HRP-2, HDGFRP2) carries
both a PWWP and an IBD (Fig. 2A) [45].
LEDGF/p75 was first picked up as the principal cellular
binding partner of HIV IN by co-immunoprecipitation [11].
Later, mutagenesis, RNA interference, transdominant over-
expression of the IBD and cellular knockout studies
corroborated its role in HIV-1 replication [46–54]. Mutagenesis
studies and X-ray crystallography were employed to unravel
themolecular details of the LEDGF/p75-IN interaction (Fig. 2B)
[48, 55, 56]. The main interaction interface is formed between
the IBD of LEDGF/p75 and the catalytic core domain of IN. In
part by binding across the IN dimer interface, LEDGF/p75
modulates IN multimerisation and activity [11].
LEDGF/p75 depletion reduces HIV-1 integration and
shifts integration preferences away from active genes [53, 57,
58]. In agreement with this, mapping LEDGF/p75 chromatin
occupancy revealed that LEDGF/p75 associates with active
regions proportional to their transcriptional output [59].
Additionally, chimeric tethers, in which the N-terminal
chromatin-binding portion of LEDGF/p75 has been replaced
by chromatin reader modules of other proteins, shifted viral
integration into regions normally recognised by the other
protein [60–62]. In the current model, LEDGF/p75 tethers the
PIC to actively transcribed chromatin, biasing integration
towards these regions (Fig. 3).
Upon LEDGF/p75 knockout, integration into active genes
still occurs more frequently than statistically expected. Part
of the remaining bias is ascribed to HRP-2 [63, 64]. Likely
owing to its lower affinity for HIV-1 IN and a generally lower
expression level, HRP-2 only plays a role in HIV integration
Figure 2. Lenti- and gammaretroviral INs interact with specific host
chromatin readers. A: Domain overview of both the p52 and p75 splice
variants of H. sapiens LEDGF and HRP-2. Abbreviations: PWWP, Trp-
Pro-Pro-Trp; NLS, nuclear localization signal; AT-hook, AT-hook minor
groove DNA binding motif; SRD, supercoiled-DNA recognition region;
IBD, integrase-binding domain. Boxes highlight, from left to right,
structures of a PWWP domain bound to a methylated histone peptide
(red), an AT-hook motif (red) bound into the DNA minor groove and the
IBD. B: Interaction of the LEDGF/p75 IBD (cyan) and an IN catalytic core
domain dimer (green and yellow). Although the CCD of IN is essential
and sufficient for interaction with LEDGF/p75, a second interface exists
involving an acidic patch on the IN N-terminal domain and a
complementary basic patch on the IBD [46, 125]. C: Domain overview
of H. sapiens bromo- and extraterminal domain containing (BET)
proteins. Abbreviations: Bromo, bromodomain; motif A, 15aa con-
served motif that may contribute to chromatin binding; NPS, N-terminal
cluster of phosphorylation sites; BID, basic residue-enriched interaction
domain; ET, extraterminal domain; SEED, Ser/Glu/Asp-rich C-terminal
cluster of phosphorylation sites; CTM, C-terminal motif [66, 71, 126].
Boxes highlight, from left to right, the structures of a bromodomain
bound to a polyacetylated histone peptide (red) and the ET domain. D:
Structure of the ET domain. Residues implicated in several interaction
studies with MLV IN are coloured red and can be seen lining a cleft on
the domain surface. E: Sequence alignment of the C-terminal tails of
various gammaretroviral INs showing strong conservation of a 16aa
BET ET domain binding motif. Abbreviations: AVIRE, Avian reticuloendo-
theliosis virus (UniProtKB accession: P03360); MoMLV, Moloney murine
leukaemia virus (P03355); AKV MLV, AKV murine leukaemia virus
(P03355); MCFF MLV, Mink cell focus-forming murine leukaemia virus
(P16103); Friend MLV, Friend murine leukaemia virus (P26809); Cas-Br-
E MLV, Cas-Br-E murine leukaemia virus (P08361); BAEV, Baboon
endogenous virus (P10272); FEV, Feline endogenous virus (P31792);
GALV, Gibbon ape leukaemia virus (P21414); WMSV, Woolly monkey
sarcoma virus (P03359); KORV, Koala retrovirus (Q9TTC1).
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site targeting when LEDGF/p75 is absent [50, 54]. Never-
theless, a substantial preference for active genes remains in
doubly depleted cells, supporting the involvement of
additional factors such as IN itself and nuclear topology
[63, 64].
BET proteins direct gammaretroviral PICs to
active enhancers
When p12 orchestrates capsid disassembly upon host cell
mitotic exit, the core gammaretroviral PIC is released into the
nucleoplasm. The intasome then recognises its specific
chromatin reader cofactors, which tether the complex to
active enhancers. While an initial yeast two-hybrid screen
revealed, among many others, the BET protein BRD2 as a
potential IN interaction partner [65], it was not until 2013 that
three groups independently identified BET proteins as bona
fide gammaretroviral integration cofactors [12–14].
The BET protein family includes BRD2, -3 and -4, which
are ubiquitously expressed and BRDT, which is restricted to
the testes [66] (see [67] for a recent review). BET proteins
are transcriptional co-regulators characterised by one
(plants) or two (fungi/animals) bromodomains at their N-
terminus, followed by an extraterminal (ET) domain
(Fig. 2C). The dual bromodomain module bestows BET
proteins with a preference for hyper-acetylated tails of
histone H3 and H4 [68–70]. The ET domain is a protein-
protein interaction hub, connecting BET proteins to several
other coactivators [67].
The interaction between BET proteins and MLV IN
involves the BET ET (Fig. 2D) domain and the flexible C-
terminal tail of IN [12, 71]. A 16 aa motif, conserved
specifically among gammaretroviruses is essential and
sufficient for binding (Fig. 2E) [12, 72]. Specifically, alanine
substitution of a single conserved Trp
residue in MLV IN (W390A) was sufficient
to abolish the interaction [12, 73].
Support for an integration targeting role
of BET proteins came from several direc-
tions. First, the BET protein chromatin-
binding profile showed remarkable overlap
with MLV integration sites [12, 13]. Second,
BET knockdown or specific inhibition of
BET chromatin tethering through the use of
bromodomain inhibitors attenuated MLV,
but not HIV replication and blocked
integration of MLV-derived viral vectors
[12–14]. When scrutinised under these
conditions, integration shifted away from
enhancer elements [13]. Third, a hybrid
tethering factor, containing the chromatin-
binding part of LEDGF/p75 and the MLV IN-
binding part of BRD4, redirected MLV
integration into active transcription units,
a pattern reminiscent of HIV integration
[12]. Taken together, these findings firmly
established BET proteins as specific medi-
ators of integration target site selection for
gammaretroviruses (Fig. 3).
Hitting the spot: The viral integrase
determines the precise insertion site
LEDGF/p75 and BET proteins, respectively, guide the lenti-
and gammaretroviral PICs to distinct chromatin contexts
(Fig. 3). Subsequently, IN selects the final site as the intasome
recognises a target DNA (tDNA) strand and catalyses the
cutting and joining reactions that fuse viral and host genomes.
Retroviral IN contains three structurally conserved
domains, connected through flexible linkers (Fig. 4A; see
[74] for a recent review). X-ray crystal structures of the
spumaviral Prototype Foamy Virus (PFV) intasome complex
have boosted our understanding of the retroviral integration
machinery [9, 10]. The intasome consists of a dimer of IN
dimers assembled on the two viral DNA LTR ends (Fig. 4C).
After processing the viral DNA ends, the complex captures a
tDNA duplex in a groove between its inner monomers (Fig. 4C,
the target capture complex, TCC). In a reaction called strand
transfer, the viral DNA ends are inserted 4–6 bp apart
(depending on the retroviral species) into opposing strands
of the tDNA [75]. The remaining single-strand gaps are
repaired by host-cell machinery, accordingly yielding 4–6 bp
duplications flanking the provirus.
Nucleosomes are the natural target for
integration and induce further biases
When bound to the intasome, the tDNA is considerably kinked
in order to correctly position the scissile phosphodiester
bonds in the two active sites [10]. This structure is in
agreement with early observations that integration is favoured
at inherently bendable sites, and specifically on nucleosomal
Figure 3. Host cofactors steer the PIC to specific chromatin environments. Example of
retroviral integration in a chromatin contact domain with an active enhancer – promoter
loop driving expression of a downstream gene. Retroviral PICs hijack distinct host
proteins to steer themselves into specific chromatin environments. The lentiviral PIC is
tethered by LEDGF/p75 to actively transcribed regions of the chromatin decorated with
H3K36me3 marks. In the case of gammaretroviruses, the intasome recruits BET proteins
recognizing hyperacetylated histones H3 and H4 at active promoter-proximal as well as
distal enhancer elements.
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DNA [76, 77]. Results from cellular integration site sequencing
suggest that integration is directed into outward-facing major
grooves on nucleosomal DNA [78, 79].
Recentwork confirms that thePFV intasome is able to stably
capture and efficiently catalyse integration into mononucleo-
somes [80]. Integration occurs preferentially at two possible,
symmetricpositions, 3.5 turnsof theDNAhelix (36bp)away
from the nucleosome dyad axis (Fig. 4B) [80]. Cryo-electron
microscopy of the intasome-nucleosome complex revealed an
extensive interaction interface [80]. The contacts with the
integration-targeted gyre of the nucleosomal DNAare similar to
those observed previously in the PFV intasome TCC structure
(Fig. 4C) [10, 80]. The second gyre is cradledbyoneof the two IN
dimer interfaces and an inner subunit interactswith thehistone
H2B C-terminal helix (Fig. 4B). Additional contacts exist
between the histone H2A N-terminal tail and the C-terminal
domain of an inner subunit of the intasome and between the C-
terminal domains of the outer subunits and other parts of the
nucleosome (Fig. 4B). These contactsmayallow the intasome to
decode epigenetic marks [80], a situation reminiscent of the
distantly related chromovirus Ty3/Gypsy LTR retrotransposons
which encode a chromodomain at their INC-terminus, allowing
them to read histone modifications and steer integration [81].
Indeed,mutagenesis of residues in contactwith the secondgyre
of DNA or with H2B reduced the PFV bias towards gene poor,
lamin-associated heterochromatin [80].
In order to avoid steric clashes, the intasome ‘lifts’ the
DNA from the surface of the nucleosome (Fig. 4B). As a result,
Figure 4. Integrase determines the precise insertion site. A:
Domain structure of HIV-1 and MLV IN. All retroviral INs contain
three structurally conserved domains connected through flexible
linkers: an N-terminal Zn2þ-binding domain, a catalytic core
domain harbouring the characteristic DD-X35-E triad motif to
chelate two catalytic Mg2þ ions, and a C-terminal SH3-like domain
(NTD, CCD and CTD, respectively). Spuma- and most likely
gammaretroviral INs contain an additional NTD-extension domain
(NED). B: Retroviral integration into nucleosomal DNA. The first
two panels show the integration hotspots at 3.5 turns of DNA
from the nucleosome dyad axis. The right panel suggests a
general model for retroviral integration. The intasome is tethered to
one or several nucleosomes through a host cofactor. Through
extensive interactions with both the targeted- and non-targeted
DNA gyre and several core histones (potentially sensing epigenetic
marks), the intasome discriminates different nucleosomes and
determines the final integration site. C: Structure of the PFV
intasome target capture complex (central) consisting of a dimer of
IN dimers assembled on the two viral DNA LTR ends. The
complex is docked onto a target DNA strand (bottom). Boxes on
either side highlight direct aa – tDNA base contacts in the
complex using HIV-1 numbering. Target DNA bases are numbered
starting from the sites of strand transfer on both strands. D:
Sequence logos of HIV-1 integration sites of wild type (WT) and
two variant viruses (INR231G and INS119G), representing their
intasome footprints on the tDNA. Arrows denote the sites of
strand transfer (position 0) on the plus (black) and minus (grey)
strands. A B-DNA representation of the tDNA with the different
aa-base contacts is placed on top and positions correspond
directly to those in the sequence logo. Positions where base
preferences are significantly different from wild type HIV-1 are
coloured [85, 86].
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sequences yielding less stable nucleosomes appear to be
better targets for capture by the intasome. Histone variants
may influence integration site preferences in a similar fashion.
The histone H2A L1-loop directly underlies the integration
hotspots and shows considerable variation, resulting in
differential stability of nucleosomes containing certain H2A
variants [80, 82]. Asymmetry of the nucleosomal DNA
sequence may also be expected to bias towards one of the
preferred sites.
On a side note, nucleosomal capture may explain the site-
specificity of HIV-1 integration events observed in Alu
elements [17]. Alu elements contribute to nucleosome
positioning in the primate genome, with each dimeric Alu
element having two fixed nucleosome slots [83, 84]. The first
of these positions a nucleosome in such a manner that the
integration hotspot in the Alu element precisely overlaps one
of the two hotspots on the nucleosome.
Intasome—tDNA base contacts induce
integration site sequence preferences
Molecular recognition between retroviral intasome and
nucleosome biases the integration site distribution. Two
recent studies employed the structure of the PFV intasome
TCC to predict and modify IN – tDNA contacts in the context
of HIV-1 infection (Fig. 4C) [85, 86]. Two IN aa – tDNA base
contacts have been discerned in the retroviral intasome, and
these directly induce palindromic sequence preferences
owing to the intasome central dyad axis (Fig. 4C and D) [10,
86]. Using HIV-1 numbering, the first is IN119, which projects
directly into the tDNA minor groove, contacting base pairs
at positions 2 and 3, as numbered from the sites of
strand transfer (position 0). IN231 in HIV-1 is the second site:
it extends into the tDNA major groove and interacts with
base pairs 0 and 1. IN119 is a highly polymorphic position
in HIV-1 IN that varies amongst retroviruses as well.
Position IN231 is conserved in lentiviruses, but the loop in
which it is located varies considerably among retroviruses.
Different amino acids at these two positions yield distinct
local sequence biases for viral integration [85, 86]. These
residues additionally modulate central tDNA bending:
where interactions at IN231 can be envisioned to act as a
tether, pulling the tDNA into the active sites, bulky aa at
IN119 push it down at the sides, requiring stronger distortion
in the centre [86].
IN119 and IN231 directly shape nucleotide preferences at
tDNA positions4 to 0 (Fig. 4D). At the site of strand transfer,
retroviruses bias against T as its methyl group sterically
hinders the transesterification reaction [10]. Finally, as the
tDNA is kinked most profoundly between the two sites of
strand transfer (positions 1–3) and no aa – base contacts are
established in this region, intrinsic bending potential dictates
the nucleotide preferences [10, 85, 86]. Depending on the size
of the integration stagger, the deformationmay be spread over
2–4 bp. In PFV with its 4 bp stagger, the centre of the
integration site is preferentially occupied by flexible pyrimi-
dine – purine dinucleotides [10]. In the case of HIV and other
retroviruses with a 5 bp stagger, minor groove compressible
WWW trinucleotides such as AAA, AAT or TAA and their
reverse complements dominate positions 1–3 of the integra-
tion site consensus (Fig. 4D) [86, 87].
In conclusion, capture of a target duplex by the retroviral
intasome directly imposes additional restraints on the integra-
tion site, yielding fine-grained biases in the distribution.
Local DNA contacts affect genome-wide
integration site distribution
IN – tDNA base contacts in the retroviral intasome provide
mechanistic insights into the local sequence preferences for
viral integration. HIV-1 variants INS119G and INR231G however,
additionally direct integration into globally less gene-dense
regions when compared to the wild-type INS119-R231 virus [86].
The INS119G and INR231G variants exhibit wild-type catalytic
activity but alter tDNA bending requirements and conse-
quently may reduce the shape and/or electrostatic compat-
ibility with certain nucleosomes [86]. These variants may
prefer integration into the weakly bound nucleosomes present
in GC-poor regions, which are generally also gene poor.
Interestingly, INS119G and INR231G viruses were associated with
a more rapid disease progression in a subset of antiretroviral
naive, HIV-1 subtype C chronically infected participants of the
Sinikithemba cohort [86]. Additional data are required though
to corroborate the observed correlation between altered
intasome target site selection in these variants and viral
fitness or pathogenesis.
Aside from local preferences, IN contact variants with
different parts of the nucleosome can affect large-scale biases
in the integration site distribution. These global effects have
now been demonstrated for HIV-1 [86] and PFV [80] and are
expected to generalise to other retroviruses.
Selection pressure can directly impinge on
intasome target specificity
The prevalence of IN119 and IN231 variants differs among HIV
subtypes, implying that integration preferences differ slightly
among subtypes [86]. Additionally, HIV-1 IN119 polymor-
phisms are subject to selection pressure from different
sources. INS119R for instance was recently found to be an
immune escape variant selected for by the HLA-C05 allele
[88]. Similarly, several HIV-1 IN119 variants change prevalence
in INSTI-untreated versus -treated patients, and they have
been described as secondary resistance mutations [89–91].
IN119, thus, represents a position of close interaction between
immune and drug selection pressure on the one hand and
HIV-1 integration site targeting on the other. While these
examples are specific to HIV-1, it is clear that any selection
pressure acting on positions homologous to HIV-1 IN119/231 in
other retroviruses will influence intasome target site selection.
Proviral transcriptional activity
determines the fate of the infection
At this point, the retrovirus has become an integral part of the
host genome. Proviral transcriptional activity determines the
....Prospects & Overviews J. Demeulemeester et al.
7Bioessays 37: 0000–0000, 2015 The Authors. Bioessays published by WILEY Periodicals, Inc.
R
e
v
ie
w
e
s
s
a
y
s
ensuing course of the infection, and reshapes the integration
site distribution in the population of infected cells. The
activity of the viral promoter shortly after infection is
probabilistically determined by a variety of cellular tran-
scription factors binding their cognate recognition sequences
in the retroviral LTR [92] (Fig. 5). Additionally, LTR activity
depends on the chromatin environment [93, 94]. Together,
these factors result in a range of intrinsic basal transcriptional
states for the provirus (Fig. 5).
Spuma-, lenti-, delta- and epsilonretroviruses encode their
own transcriptional master regulators, while alpha-, beta- and
gammaretroviruses rely more on host transcription factors.
The HIV trans-activator of transcription (Tat) protein amplifies
stochastic expression from the LTR promoter and establishes a
positive feedback loop (Fig. 5, [95], reviewed in [96]). The
architecture of this regulatory circuit (and perhaps those of
other retroviral genera) creates a phenotypic bifurcation: the
provirus can be transcriptionally active or quiescent. In the
first case, progeny virions are rapidly produced, whereas in
the second case, the provirus enters a potentially long-lived
latent state. Simulations of Tat protein levels in cells suggest
stochastic switching between the two states (transcriptional
shutdown or reactivation of the provirus) is possible under a
wide array of conditions [97]. The latently infected cells
constitute a reservoir for the virus and represent a major
hurdle towards obtaining a functional HIV-1 cure. As will be
discussed in the last section, recent reports suggest that some
latently infected cells are actively proliferating and contribute
to the reservoir under antiretroviral treatment [18, 19].
It is worth mentioning the phenomenon of superinfection
resistance (SIR), in which an infected cell becomes resistant to
superinfection by a similar type of virus. SIR has been
described in several groups of viruses. As virus-encoded
proteins are usually responsible, SIR is directly related to
integration and transcription in retroviruses. Often, viral (or
host-acquired) Env expression is found to interfere with
infection, simply by occupying the cellular receptors for viral
entry [98]. The spumaviral Bet gene (Between-env-and-LTR-1-
and-2) contributes to SIR and inhibits expression of the viral
transcriptional master regulator (Tas) to maintain the original
latently infected cell [98]. In the case of HIV-1, the
mechanisms of SIR are not well understood [98]. Nevertheless,
SIR is far from absolute. Both in HIV-1 and HTLV-1 infected
patients, evidence suggests a small percentage of the infected
cells may harbour multiple proviruses [99, 100]. In such cases,
superinfection and viral recombination during the next round
could be of evolutionary significance [101].
The chromatin environment influences proviral
activity
Several studies of chromatin position effects on gene
expression from the HIV-1 LTR or active promoters showed
that variability in the integration site affects transcriptional
kinetics and can result in up to 1,000-fold differences in
expression level [93, 94, 102, 103]. Besides cis-effects, also
Figure 5. Simplified model of HIV-1 proviral transcription. The
chromatin context, both in cis and in trans, together with the
presence of various LTR-binding transcription factors, probabilisti-
cally determine intrinsic proviral activity through various other
coactivators and chromatin modifiers. When the viral trans-activator
of transcription (Tat) accumulates beyond a critical threshold, it binds
the trans-activation response (TAR) RNA stem-loop at the 50 end of
nascent viral transcripts and recruits P-TEFb. P-TEFb phosphory-
lates RNA Pol II as well as its pausing factors enabling productive
elongation. Amplification of stochastic viral expression by this Tat
positive feedback creates a robust latency switch. By influencing the
intrinsic LTR activity, the chromatin context and hence integration
site selection influences the parameters of the switch, resulting in
different probabilities for the ON and OFF states. Recognizing viral
latency as a bet hedging strategy, integration site selection holds
important consequences for virus evolution.
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long-range topological interactions are known to affect
proviral activity (Fig. 5) [104, 105]. At least for HIV-1 and
HTLV-1, proviral (and host gene) transcription is affected by
the orientation of the integrated retrovirus through transcrip-
tional interference [7, 106–108].
Proviruses integrated in the same genomic neighbourhood
in different cells tend to have the same activation status,
corroborating the existence of local features influencing
latency [109]. Nevertheless, the precise nature of these (epi-)
genomic features remains to be identified [108–110]. For
HTLV-1, specific transcription factor binding sites and the
relative position of the nearest host gene as well as its relative
orientation have been linked to proviral expression [108].
The chromatin environment determines the threshold
level of transcription factors required to induce LTR-driven
gene expression (Fig. 5) [111]. Although the study was
performed with HIV-1, chromatin likely modulates tran-
scription factor binding and activation in similar ways on all
retroviral LTRs. Taken together, the results support the notion
that intrinsic LTR activity is governed by the chromatin
environment in combination with the available transcription
factors (Fig. 5).
Integration site targeting is subject to
natural selection: Latency and bet
hedging
The Tat circuit is optimised to amplify stochastic fluctuations
in gene expression [92, 95, 112]. Tat feedback is sufficient to
induce a robust, probabilistic latency switch independent of
cellular activation state [97]. In agreement with the hardwiring
of this switch, the latency programme was proposed to
represent a bet hedging strategy. Bet hedging is an evolu-
tionary strategy based on stochastic phenotype switching that
optimises survival in fluctuating or unfavourable environ-
ments. In the case of HIV-1, a stochastic latency switch may
allow the virus to maximise transmission by reducing
extinction during mucosal infections while maintaining
sufficiently high-plasma viral loads later on [113].
While the switch itself is always present, LTR activity,
determined by transcription factors and chromatin environ-
ment, directly modulates the probabilities of a provirus being
in the ON or the OFF states, and hence the population of latent
and productively infected cells [97]. As it affects the
probabilistic parameters of the latency switch, the integration
site represents an inherent part of the viral bet hedging
strategy and can be subject to direct evolutionary optimisa-
tion. For instance, consistent integration at permissive or
repressive sites results in more proviruses in the ON or OFF
state, respectively. Both scenarios are selected against due to a
reduced transmissibility [113].
Not all retroviruses encode a positive transcriptional
feedback loop. Nevertheless, similar bet hedging strategies
may be adopted by other genera besides lentiviruses. Proviral
transcription is inherently noisy, potentially magnified by the
formation of a gene loop joining 50 LTR promoter and 30 LTR
poly(A) signal [114, 115]. Such loops are also observed at
various cellular promoters where they impose transcriptional
directionality and allow efficient recycling of the RNA Pol II
machinery [115]. Intrinsic transcriptional bursting from a
retroviral LTR, modulated in frequency and size by the
chromatin context and the presence of cognate host tran-
scription factors, may provide enough variability to create
repressed and permissive proviral states. Even without a
positive feedback loop, integration site selection could thus be
part of an evolutionary optimised bet hedging strategy. In this
case, the phenotypic switching parameters are likely to be
more dependent on host-transcription factors and the proviral
chromatin context. The MLV preference for strong enhancer
elements for instance may be an adaptation to guarantee close
interactions with the transcriptional machinery [4, 5].
Of note, theory predicts that modulating the latency
switch to result in a latent provirus in 90–95% of infected cells
would push the basic reproduction number of HIV below one,
resulting in an unsustainable infection [113]. Thismay prove to
be a viable alternative to shock-and-kill strategies and could
be envisioned using Tat antagonists [116, 117], but also with
modulators of integration site targeting, chromatin or tran-
scription factors.
The fact that LEDGF/p75 depletion hampers HIV-1
replication [54, 64], is in line with a fitness advantage
through integration site selection. However, as LEDGF/p75
affects IN oligomerisation as well as integration site targeting,
it is difficult to uncouple these contributions. MLV-derived
viral vectors deficient for interaction with BET proteins suffer
no or only a marginal reduction in transduction efficiency in
vitro [73, 118]. The effect of these mutants on multiple round
viral replication (in vivo) however, remains to be determined.
Selective forces in the host shape the
final integration site distribution
In vivo, selection forces continuously reshape the integration
site landscape. Integration events at loci that support high
expressionwill probabilistically lead tomore active proviruses
[93, 94, 109]. In turn, these cells are likely to be weeded out by
the immune system or die due to viral cytopathic effects [119].
In the case of HTLV-1, negative selection on the integration
site distribution is dominant during chronic infection [7].
Reciprocally, infected cells with a growth advantage may
increase in number, for instance due to an oncogenic
integration event, antigen stimulation or homeostatic pro-
liferation [18, 19, 120, 121].
BET proteins steer gammaretroviral integration into strong
promoter-proximal as well as distal enhancer elements [4, 5].
In both cases insertional mutagenesis can lead to oncogene
activation and ultimately malignant transformation of the
host cell [122]. Insertion of an LTR in a promoter can easily be
envisioned to result in transcriptional deregulation. Distal
enhancers are brought into contact with promoters through
DNA looping (Fig. 3) [123]. Integration of an LTR enhancer in a
distal regulatory region can similarly lead to activation of the
target promoter via these three-dimensional interactions, as
commonly observed among oncogenic MLV integrations [122].
Recent studies have found that also HIV integration can
lead to clonal expansion [17–19]. HIV integration into specific
cancer-associated genes may occasionally yield a cellular
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survival advantage, promoting expansion and viral persis-
tence. At least in one case a prominent clone has been found to
perpetuate the infectious viral reservoir by producing
replication-competent virus in sufficient quantities to cause
viraemia [18]. It remains to be determined whether this finding
turns out to be a general one and not all expanded clones
harbour defective viruses [17–19].
Driving proliferation of the host cell may be an inherent
part of the general retroviral evolutionary strategy. While
some non-acutely transforming viruses encode their own
oncogenes (e.g. HTLV Tax and HBZ), others cause trans-
formation of the host cell through insertional mutagenesis.
The efficiency of cellular transformation differs considerably
between retroviruses, in agreement with varying contribu-
tions to the strategies of different retroviral genera. Logically,
the mutagenic potential of a retrovirus relies, at least in part,
on its specific integration site biases. Integration site selection
therefore contributes to this strategy as well.
Considering the potential of retroviruses to drive host cell
proliferation together with stochastic viral gene expression,
one may envision a reservoir of latently infected, clonally
expanding cells, carrying genetically identical virus that
stochastically pops up (blips). In agreement with this,
genetically identical HIV variants have been reported to
emerge after long-term suppressive antiretroviral therapy
[124].
Conclusions: Site matters
It has become clear that retroviral integration site selection is
an intricate multistep process that starts with the mode of
nuclear entry of the viral PIC (Fig. 6). Similar to the ancestral
LTR retrotransposons, retroviruses co-opt host factors to guide
the viral integration machinery to specific chromatin environ-
ments (Fig. 6). Lentiviruses grab hold of the chromatin reader
LEDGF/p75, directing integration into actively transcribed
regions. Likewise, gammaretroviruses target enhancers by
adopting BET proteins as chaperones for their integrase. Both
LEDGF/p75 and BET proteins are chromatin readers, and have
ample binding sites across the genome. The invading PIC
therefore likely encounters an environment suitable for
integration soon after it enters the nucleus. Tethered to
specific chromatin regions, the intasome captures a nucleo-
some and catalyses the cutting and joining reactions fusing
the viral and host genomes, to pin down the final integration
site (Fig. 6). Direct contacts of the intasome with target DNA
bases, the intrinsic bendability of the sequence, and contacts
with the rest of the nucleosome further bias the integration
site distribution (Fig. 6).
Upon establishment of the provirus, the available
transcription factors and the chromatin context probabilisti-
cally affect the course of the infection. Importantly, by
modulating the probabilities of switching between proviral
ON and OFF states, the integration site selection processes of
retroviruses may be part of a bet hedging strategy and could
have been optimised through natural selection. Finally, in
vivo, the integration site distribution is continuously
reshaped by selection processes such as immune pressure
and the viral cytopathic effect, but also by clonal expansion,
either passively or actively due to insertional mutagenesis
(Fig. 6).
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